Related Experiment Videos
[Use of cyclophotocoagulation with diode laser in treatment of secondary glaucoma in children]
D Klimczak-Slaczka1, M E Prost
1Z Kliniki Okulistyki Instytutu Pomnik-Centrum Zdrowia Dziecka Kierownik.
Insights
Transscleral diode laser cyclophotocoagulation effectively treats secondary glaucoma in children when other methods fail. This safe procedure significantly reduces intraocular pressure in pediatric patients.
Area of Science:
- Ophthalmology
- Pediatric Glaucoma Research
Context:
- Secondary glaucoma in children presents unique challenges.
- Management often requires advanced therapeutic options.
- Limited treatment efficacy and high surgical risks necessitate alternative interventions.
Purpose:
- To assess the efficacy of transscleral diode laser cyclophotocoagulation (TDLC) for pediatric secondary glaucoma.
- To evaluate TDLC in cases refractory to conventional treatments or with high surgical risks.
Summary:
- Fifty pediatric eyes with secondary glaucoma underwent TDLC.
- Intraocular pressure reduction below 23 mm Hg was achieved in 40% at 1 month and 68% at 6 months.
- Post-traumatic glaucoma showed less favorable outcomes.
Impact:
- TDLC offers a safe and effective therapeutic avenue for pediatric secondary glaucoma.
- This procedure is a viable option for cases unresponsive to medical or surgical management.
- Provides a crucial treatment modality for complex pediatric glaucoma cases.
Aim Of The Paper:
To evaluate the effectiveness of transscleral diode laser cyclophotocoagulation in treatment of secondary glaucoma in children.
Material And Methods:
50 children (50 eyes) with secondary glaucoma (aphakic, posttraumatic, in Sturge-Weber syndrome and in aniridia) which was uncontrolled with medical and surgical therapy or the surgery had a high risk of postoperative complications. In all patients diode laser transscleral cyclophotocoagulation has been performed.
Results:
After one month intraocular pressure was reduced (with or without medical treatment) below 23 mm Hg in 40% of patients and after 6 months in 68% of patients. The worst results were observed in posttraumatic glaucoma.
Conclusion:
Diode laser transscleral cyclophotocoagulation is a safe and effective method of secondary glaucoma therapy in children uncontrolled with other methods of medical and surgical therapy or when the surgery has a high risk of postoperative complications.